Article Link: FDA Approves Yescarta (axicabtagene ciloleucel) CAR-T Cell Therapy to Treat Adults with Certain Types of Large B-Cell Lymphoma �...
Janssen Announces FDA Approval of Stelara (ustekinumab) for the Treatment of Adolescents with Moderate to Severe Plaque Psoriasis
Article Link: Janssen Announces FDA Approval of Stelara (ustekinumab) for the Treatment of Adolescents with Moderate to Severe Plaque Psoriasis ...
FDA Approves Lyrica CR (pregabalin) Extended-Release Tablets for Neuropathic Pain Conditions
Article Link: FDA Approves Lyrica CR (pregabalin) Extended-Release Tablets for Neuropathic Pain Conditions Source: FDA New ...
Flexion Therapeutics Announces FDA Approval of Zilretta (triamcinolone acetonide extended-release injectable suspension) for Osteoarthritis Knee Pain
Article Link: Flexion Therapeutics Announces FDA Approval of Zilretta (triamcinolone acetonide extended-release injectable suspension) for Osteoarthri...
FDA Approves Botox Cosmetic (OnabotulinumtoxinA) for the Temporary Improvement in the Appearance of Moderate to Severe Forehead Lines
Article Link: FDA Approves Botox Cosmetic (OnabotulinumtoxinA) for the Temporary Improvement in the Appearance of Moderate to Severe Forehead Lines�...
FDA Approves Ascor (Ascorbic Acid Injection, USP) for the Treatment of Scurvy
Article Link: FDA Approves Ascor (Ascorbic Acid Injection, USP) for the Treatment of Scurvy Source: FDA New Drug Approvals
Novo Nordisk Receives FDA Approval for Fiasp (insulin aspart injection), a New Fast-Acting Mealtime Insulin
Article Link: Novo Nordisk Receives FDA Approval for Fiasp (insulin aspart injection), a New Fast-Acting Mealtime Insulin S...
FDA Approves Verzenio (abemaciclib) for Certain Advanced or Metastatic Breast Cancers
Article Link: FDA Approves Verzenio (abemaciclib) for Certain Advanced or Metastatic Breast Cancers Source: FDA New Drug Ap...
FDA Approves Verzeniov (abemaciclib) for Certain Advanced or Metastatic Breast Cancers
Article Link: FDA Approves Verzeniov (abemaciclib) for Certain Advanced or Metastatic Breast Cancers Source: FDA New Drug A...
FDA Approves Merck’s Keytruda (pembrolizumab) for Previously Treated Patients with Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Whose Tumors Express PD-L1
Article Link: FDA Approves Merck’s Keytruda (pembrolizumab) for Previously Treated Patients with Recurrent Locally Advanced or Metastatic Gastric or G...
